CLINICAL_TRIALS
trial_result
· 2019-03-05
Clinical Trial Update: A Pilot Dose-Response Biomarker Study of Brexpiprazole Treatment in PTSD [Phase 2]
Summary
Phase 2 pilot dose-response biomarker study of brexpiprazole in PTSD was terminated; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Duke University | Conditions: Post Traumatic Stress Disorder | Phase 2 | Status: TERMINATED | Results posted: 2019-03-05